About: Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.34 (+15.52%)
ILA ASX Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd share price
ILA price activity
Last Price
$0.340
Change (24hr)
0.05 AUD (15.52%)
Volume
183.25K
Volume (4w avg)
-
Open
$0.30
Day Range
$0.30 - $0.35
Previous Close
$0.29
Last Trade
05 Nov, 5:10 am GMT+0
Delayed
05 Nov, 5:10 am GMT+0
ILA price performance
Delayed
05 Nov, 5:10 am GMT+0
ILA details
ILA Market Signals